| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 4.01e-13 | 46 | 54 | 8 | GO:0030020 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL4A1 COL23A1 COL24A1 COL7A1 COL8A1 COL9A2 HMCN2 COL6A5 COL22A1 | 1.77e-09 | 188 | 54 | 9 | GO:0005201 |
| GeneOntologyMolecularFunction | structural molecule activity | COL4A1 COL23A1 COL24A1 COL7A1 COL8A1 COL9A2 HMCN2 NUP88 COL6A5 COL22A1 | 1.19e-04 | 891 | 54 | 10 | GO:0005198 |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL4A1 COL23A1 COL24A1 COL7A1 COL8A1 COL9A2 ADAMTS7 COL22A1 SPINK5 | 3.81e-07 | 377 | 52 | 9 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL4A1 COL23A1 COL24A1 COL7A1 COL8A1 COL9A2 ADAMTS7 COL22A1 SPINK5 | 3.89e-07 | 378 | 52 | 9 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL4A1 COL23A1 COL24A1 COL7A1 COL8A1 COL9A2 ADAMTS7 COL22A1 SPINK5 | 3.98e-07 | 379 | 52 | 9 | GO:0045229 |
| GeneOntologyCellularComponent | collagen trimer | COL4A1 COL23A1 COL24A1 COL7A1 COL8A1 COL9A2 CCBE1 COL6A5 COL22A1 | 1.24e-12 | 88 | 54 | 9 | GO:0005581 |
| GeneOntologyCellularComponent | extracellular matrix | COL4A1 COL23A1 COL24A1 COL7A1 COL8A1 COL9A2 HMCN2 ZAN ADAMTS7 CCBE1 HNRNPM COL6A5 CPZ COL22A1 | 7.97e-10 | 656 | 54 | 14 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL4A1 COL23A1 COL24A1 COL7A1 COL8A1 COL9A2 HMCN2 ZAN ADAMTS7 CCBE1 HNRNPM COL6A5 CPZ COL22A1 | 8.29e-10 | 658 | 54 | 14 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL4A1 COL23A1 COL24A1 COL7A1 COL8A1 COL9A2 HMCN2 HNRNPM COL6A5 COL22A1 | 8.86e-07 | 530 | 54 | 10 | GO:0062023 |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 2.05e-06 | 332 | 54 | 8 | GO:0005788 | |
| GeneOntologyCellularComponent | basement membrane | 1.57e-05 | 122 | 54 | 5 | GO:0005604 | |
| GeneOntologyCellularComponent | phagophore | 1.96e-05 | 3 | 54 | 2 | GO:0061908 | |
| GeneOntologyCellularComponent | complex of collagen trimers | 2.10e-05 | 21 | 54 | 3 | GO:0098644 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 1.82e-04 | 8 | 54 | 2 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 1.82e-04 | 8 | 54 | 2 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 1.82e-04 | 8 | 54 | 2 | GO:0098645 | |
| GeneOntologyCellularComponent | tricarboxylic acid cycle heteromeric enzyme complex | 9.76e-04 | 18 | 54 | 2 | GO:0045239 | |
| GeneOntologyCellularComponent | phagophore assembly site membrane | 1.46e-03 | 22 | 54 | 2 | GO:0034045 | |
| GeneOntologyCellularComponent | phagophore assembly site | 4.57e-03 | 39 | 54 | 2 | GO:0000407 | |
| Domain | Collagen | COL4A1 COL23A1 COL24A1 COL7A1 COL8A1 COL9A2 CCBE1 COL6A5 COL22A1 | 2.44e-12 | 85 | 54 | 9 | IPR008160 |
| Domain | Collagen | COL4A1 COL23A1 COL24A1 COL7A1 COL8A1 COL9A2 CCBE1 COL6A5 COL22A1 | 2.44e-12 | 85 | 54 | 9 | PF01391 |
| Domain | ATG2 | 8.21e-06 | 2 | 54 | 2 | IPR026849 | |
| Domain | ATG2_CAD | 8.21e-06 | 2 | 54 | 2 | PF13329 | |
| Domain | ATG2_CAD_motif | 8.21e-06 | 2 | 54 | 2 | IPR026885 | |
| Domain | ATG_C | 8.16e-05 | 5 | 54 | 2 | PF09333 | |
| Domain | Autophagy-rel_C | 8.16e-05 | 5 | 54 | 2 | IPR015412 | |
| Domain | VWFA | 9.24e-05 | 82 | 54 | 4 | PS50234 | |
| Domain | VWA | 1.01e-04 | 84 | 54 | 4 | SM00327 | |
| Domain | VWF_A | 1.92e-04 | 99 | 54 | 4 | IPR002035 | |
| Domain | VPS13_N | 2.27e-04 | 8 | 54 | 2 | IPR026854 | |
| Domain | Chorein_N | 2.27e-04 | 8 | 54 | 2 | PF12624 | |
| Domain | VWA | 5.68e-04 | 56 | 54 | 3 | PF00092 | |
| Domain | Laminin_G | 6.30e-04 | 58 | 54 | 3 | IPR001791 | |
| Domain | - | 1.28e-03 | 74 | 54 | 3 | 3.40.50.410 | |
| Domain | FRI | 1.51e-03 | 20 | 54 | 2 | SM00063 | |
| Domain | - | 1.66e-03 | 21 | 54 | 2 | 1.10.2000.10 | |
| Domain | TSPN | 2.00e-03 | 23 | 54 | 2 | SM00210 | |
| Domain | Frizzled_dom | 2.17e-03 | 24 | 54 | 2 | IPR020067 | |
| Domain | FZ | 2.17e-03 | 24 | 54 | 2 | PS50038 | |
| Domain | Fz | 2.17e-03 | 24 | 54 | 2 | PF01392 | |
| Domain | ASX_HYDROXYL | 3.03e-03 | 100 | 54 | 3 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.57e-03 | 106 | 54 | 3 | IPR000152 | |
| Domain | ConA-like_dom | 3.68e-03 | 219 | 54 | 4 | IPR013320 | |
| Domain | EGF_3 | 4.72e-03 | 235 | 54 | 4 | PS50026 | |
| Domain | EGF_CA | 5.29e-03 | 122 | 54 | 3 | SM00179 | |
| Domain | LAM_G_DOMAIN | 5.40e-03 | 38 | 54 | 2 | PS50025 | |
| Domain | EGF-like_Ca-bd_dom | 5.54e-03 | 124 | 54 | 3 | IPR001881 | |
| Domain | EGF-like_dom | 5.79e-03 | 249 | 54 | 4 | IPR000742 | |
| Domain | Laminin_G_2 | 5.97e-03 | 40 | 54 | 2 | PF02210 | |
| Domain | EGF_1 | 6.29e-03 | 255 | 54 | 4 | PS00022 | |
| Domain | EGF-like_CS | 6.82e-03 | 261 | 54 | 4 | IPR013032 | |
| Domain | EGF_2 | 7.19e-03 | 265 | 54 | 4 | PS01186 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 5.02e-13 | 44 | 42 | 8 | M27812 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 1.76e-11 | 67 | 42 | 8 | M26999 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 2.57e-11 | 41 | 42 | 7 | MM15538 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 1.99e-10 | 90 | 42 | 8 | M631 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 4.77e-10 | 61 | 42 | 7 | MM14637 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 2.32e-09 | 76 | 42 | 7 | MM14573 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 2.37e-08 | 61 | 42 | 6 | M27103 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 3.18e-08 | 64 | 42 | 6 | M26953 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.77e-07 | 85 | 42 | 6 | M16441 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 3.52e-07 | 50 | 42 | 5 | MM14796 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.41e-06 | 300 | 42 | 8 | M610 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.90e-06 | 76 | 42 | 5 | MM14867 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 3.37e-06 | 140 | 42 | 6 | M587 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 7.02e-06 | 42 | 42 | 4 | M7169 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 9.90e-06 | 258 | 42 | 7 | MM14572 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 1.01e-05 | 46 | 42 | 4 | M198 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.79e-05 | 53 | 42 | 4 | MM14566 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 2.71e-05 | 20 | 42 | 3 | MM15061 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 3.57e-05 | 63 | 42 | 4 | M11187 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 6.73e-05 | 74 | 42 | 4 | M160 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.93e-04 | 38 | 42 | 3 | MM14969 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 3.58e-04 | 114 | 42 | 4 | MM14571 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 6.43e-04 | 57 | 42 | 3 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 6.77e-04 | 58 | 42 | 3 | M2049 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 8.88e-04 | 15 | 42 | 2 | M27161 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 1.02e-03 | 261 | 42 | 5 | M42565 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.49e-03 | 76 | 42 | 3 | M27219 | |
| Pubmed | 2.99e-10 | 175 | 54 | 8 | 28071719 | ||
| Pubmed | 1.43e-07 | 153 | 54 | 6 | 25037231 | ||
| Pubmed | 2.39e-07 | 167 | 54 | 6 | 22159717 | ||
| Pubmed | 4.10e-07 | 39 | 54 | 4 | 33580754 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 2.22e-06 | 135 | 54 | 5 | 28675934 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 28800131 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 22219374 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | CELSR1 ADAMTS7 MTOR POLG A4GALT KDM3B OGDHL ATG2A CABIN1 GGT7 | 6.76e-06 | 1105 | 54 | 10 | 35748872 |
| Pubmed | A conserved ATG2-GABARAP family interaction is critical for phagophore formation. | 7.09e-06 | 3 | 54 | 2 | 32009292 | |
| Pubmed | Collagen mRNA levels changes during colorectal cancer carcinogenesis. | 7.09e-06 | 3 | 54 | 2 | 19422682 | |
| Pubmed | Atopic Eczema: Genetic Analysis of COL6A5, COL8A1, and COL10A1 in Mediterranean Populations. | 7.09e-06 | 3 | 54 | 2 | 31275967 | |
| Pubmed | 1.42e-05 | 4 | 54 | 2 | 32326527 | ||
| Pubmed | 1.42e-05 | 4 | 54 | 2 | 33974636 | ||
| Pubmed | Macrophage autophagy in immunity to Cryptococcus neoformans and Candida albicans. | 2.36e-05 | 5 | 54 | 2 | 22710871 | |
| Pubmed | 2.36e-05 | 5 | 54 | 2 | 9169408 | ||
| Pubmed | 3.54e-05 | 6 | 54 | 2 | 30204931 | ||
| Pubmed | Assessment of a polymorphism of SDK1 with hypertension in Japanese Individuals. | 7.19e-05 | 142 | 54 | 4 | 19851296 | |
| Pubmed | Association of genetic variants with hemorrhagic stroke in Japanese individuals. | 7.39e-05 | 143 | 54 | 4 | 20198315 | |
| Pubmed | 1.06e-04 | 10 | 54 | 2 | 2446864 | ||
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 1.25e-04 | 62 | 54 | 3 | 28344315 | |
| Pubmed | 1.29e-04 | 11 | 54 | 2 | 10575226 | ||
| Pubmed | 1.38e-04 | 64 | 54 | 3 | 22261194 | ||
| Pubmed | 1.55e-04 | 12 | 54 | 2 | 28890073 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 2.57e-04 | 79 | 54 | 3 | 18757743 | |
| Pubmed | 4.42e-04 | 20 | 54 | 2 | 32511952 | ||
| Pubmed | 4.88e-04 | 21 | 54 | 2 | 27856617 | ||
| Pubmed | 6.73e-04 | 451 | 54 | 5 | 36168627 | ||
| Pubmed | mTORC1-Regulated and HUWE1-Mediated WIPI2 Degradation Controls Autophagy Flux. | 6.94e-04 | 25 | 54 | 2 | 30340022 | |
| Pubmed | 9.35e-04 | 29 | 54 | 2 | 22613833 | ||
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 1.10e-03 | 130 | 54 | 3 | 35545047 | |
| Pubmed | 1.14e-03 | 32 | 54 | 2 | 23154389 | ||
| Pubmed | 1.21e-03 | 33 | 54 | 2 | 32640236 | ||
| Pubmed | 1.22e-03 | 300 | 54 | 4 | 10591208 | ||
| Pubmed | 1.29e-03 | 34 | 54 | 2 | 10613844 | ||
| Pubmed | 1.36e-03 | 35 | 54 | 2 | 11013070 | ||
| Pubmed | 1.44e-03 | 36 | 54 | 2 | 24147044 | ||
| Pubmed | 1.54e-03 | 146 | 54 | 3 | 27068509 | ||
| GeneFamily | Collagens | 6.68e-14 | 46 | 40 | 8 | 490 | |
| GeneFamily | Autophagy related | 2.41e-03 | 33 | 40 | 2 | 1022 | |
| Coexpression | NABA_COLLAGENS | 2.59e-14 | 43 | 54 | 8 | MM17060 | |
| Coexpression | NABA_COLLAGENS | 3.16e-14 | 44 | 54 | 8 | M3005 | |
| Coexpression | NABA_CORE_MATRISOME | COL4A1 COL23A1 COL24A1 COL7A1 COL8A1 COL9A2 HMCN2 COL6A5 COL22A1 | 4.05e-09 | 270 | 54 | 9 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | COL4A1 COL23A1 COL24A1 COL7A1 COL8A1 COL9A2 HMCN2 COL6A5 COL22A1 | 4.76e-09 | 275 | 54 | 9 | M5884 |
| Coexpression | NABA_MATRISOME | COL4A1 COL23A1 COL24A1 COL7A1 COL8A1 COL9A2 HMCN2 ADAMTS7 CCBE1 COL6A5 COL22A1 | 5.41e-06 | 1008 | 54 | 11 | MM17056 |
| Coexpression | NABA_MATRISOME | COL4A1 COL23A1 COL24A1 COL7A1 COL8A1 COL9A2 HMCN2 ADAMTS7 CCBE1 COL6A5 COL22A1 | 6.40e-06 | 1026 | 54 | 11 | M5889 |
| ToppCell | 21-Trachea-Epithelial-Submucosal_gland_basal|Trachea / Age, Tissue, Lineage and Cell class | 3.98e-08 | 159 | 54 | 6 | 4f670b57b8d3b090ea2f1aafe15baf93cb7ef146 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-3|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.30e-06 | 156 | 54 | 5 | b464871ad7c8ce0d58013a27996639eac1e526d8 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.09e-06 | 172 | 54 | 5 | c6bc78fd63c9479a84ec0552b55c89750cad0fa5 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.09e-06 | 172 | 54 | 5 | bfb87a281a9cf6ad45b310bf8104fc0ab382b549 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.76e-06 | 182 | 54 | 5 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | IPF-Lymphoid-ILC_B|Lymphoid / Disease state, Lineage and Cell class | 2.84e-06 | 183 | 54 | 5 | 9b507547e6adf78e46e7f542cd9958224ec5826a | |
| ToppCell | 15-Trachea-Epithelial-Submucosal_gland_basal|Trachea / Age, Tissue, Lineage and Cell class | 3.49e-06 | 191 | 54 | 5 | 409e12d2bb26b6d2ed025304ca6ace07df16638a | |
| ToppCell | Fibroblasts-CD55+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.68e-06 | 193 | 54 | 5 | 8f4bf9a2fbedae35432dad96730b00c70185874c | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 3.68e-06 | 193 | 54 | 5 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | distal-3-mesenchymal-Myofibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.27e-06 | 199 | 54 | 5 | 1f20addc0d138fec02ed6ca4c518169c568de263 | |
| ToppCell | distal-mesenchymal-Myofibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.37e-06 | 200 | 54 | 5 | 069c8949b33ecfdb6da32992002d4060ff6082bc | |
| ToppCell | distal-mesenchymal-Myofibroblast|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.37e-06 | 200 | 54 | 5 | 61854a459385cd9295be37157a8f81a2c227dff3 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Col8a1_Rprm|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.00e-05 | 132 | 54 | 4 | 66ec5a06eece27c0aafb548f51db9fee595e71bc | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Gpr139|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.12e-05 | 134 | 54 | 4 | 917b8951dd4c870b6b92f2e73e02dac884330c30 | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast-MyoFB-3|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.18e-05 | 135 | 54 | 4 | 5b13ff740d9f7d96274aebb6b389a80f6004adc7 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.66e-05 | 142 | 54 | 4 | 7b6678a73d04feac12bbc909f2df478215511de0 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.66e-05 | 142 | 54 | 4 | 347f5832a86f4e41752e36e3e737df7ca6f79e90 | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.13e-05 | 148 | 54 | 4 | 5729826e8d45bf995e2efa6707c49e264d12d112 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.30e-05 | 150 | 54 | 4 | 7a9d6a7ff8000e9a061e1b586e4c258cc91a2a09 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.30e-05 | 150 | 54 | 4 | e5b843cb2bc847f6cab4cbec0a2a6a72fac50fee | |
| ToppCell | Control-Epithelial_airway|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.04e-05 | 158 | 54 | 4 | 35aee1c3b92169e73569331022833cb44ab7e7e8 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.14e-05 | 159 | 54 | 4 | 92049a8d8fc9997d8d0d76500c72596a9b2394e0 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 4.67e-05 | 164 | 54 | 4 | 9b4a6007abae992db871d9f6f731d5af724de30d | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Club_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.89e-05 | 166 | 54 | 4 | 1df4bdf7c773cbfa6c93d7a901f9cd3f3fe07a3d | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Club_cells-Airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.89e-05 | 166 | 54 | 4 | 9628522e7af8f8edca733588a364ab2454ac5ca5 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.01e-05 | 167 | 54 | 4 | 743df5908c1ceb43b34b240d9f9649f30f4142fa | |
| ToppCell | 3'_v3-Lung-Lymphocytic_Invariant-Inducer-like-ILC3|Lung / Manually curated celltypes from each tissue | 5.01e-05 | 167 | 54 | 4 | 0614d077b47a87f726068615548d0b0a216627be | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell-mesothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.01e-05 | 167 | 54 | 4 | 1adb566f98af0109c8cc6e36033b89651e2c75e7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.13e-05 | 168 | 54 | 4 | d19a115365c5415e51c039718d7669de788fcf33 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-05 | 169 | 54 | 4 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | facs-Heart-LV-3m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.49e-05 | 171 | 54 | 4 | c6fc9ef9735dbf5314a4c7dac2b2954b0985ae4d | |
| ToppCell | facs-Heart-LV-3m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.49e-05 | 171 | 54 | 4 | 55b194a9bf4d3e4b5d96e0d1298424359c441cbb | |
| ToppCell | wk_20-22-Mesenchymal-Chondrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.49e-05 | 171 | 54 | 4 | d2938639e9a7c349e5a6ec61724222f9d127c89f | |
| ToppCell | primary_auditory_cortex_(A1C)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.62e-05 | 172 | 54 | 4 | 20ea9db009370aa6235365ce93e153eb5b28db94 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_CPZ|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.88e-05 | 174 | 54 | 4 | ccc59416548ed3b783fd7a050ab32076c4296254 | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 5.88e-05 | 174 | 54 | 4 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-SMG_basal_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.01e-05 | 175 | 54 | 4 | 4462000b22af227555413ba202a872868eecde6c | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.14e-05 | 176 | 54 | 4 | 77c3da2eaa072a6baefb5087fd07ec18c5e271cd | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.28e-05 | 177 | 54 | 4 | 9ec7f1e64312d26d434b3312b58386715dbad644 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.28e-05 | 177 | 54 | 4 | 016277dfd59b1793fddaaadc2b3f41622d76ce3a | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.28e-05 | 177 | 54 | 4 | cbad1a23851151dbef01ea2af960e6f0944f838b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.28e-05 | 177 | 54 | 4 | ce86dfaeb74d995a19aea62f0fb15c4c0bb854b0 | |
| ToppCell | COVID-19_Mild-NK_CD56bright|COVID-19_Mild / Disease condition and Cell class | 6.56e-05 | 179 | 54 | 4 | 90e7a4af195aa2332b07a9f06cde63e72ff49255 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.70e-05 | 180 | 54 | 4 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.70e-05 | 180 | 54 | 4 | 0153667e44fdbc3c0d444dcb023069925a2b69a2 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.70e-05 | 180 | 54 | 4 | 40a28b410f46215d6d7cf8a02a18078eb046b5b0 | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.00e-05 | 182 | 54 | 4 | dc55de945c6f78f32eb3a1b3520835eb8417e068 | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.00e-05 | 182 | 54 | 4 | 010a7364da46101cb5068891fd7bc712ea8f13bd | |
| ToppCell | Mesenchymal_cells-Osteoblasts|Mesenchymal_cells / Lineage and Cell class | 7.15e-05 | 183 | 54 | 4 | d6b52d52fe9a7a6c798947f05420d79fe12e4662 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.15e-05 | 183 | 54 | 4 | f4ea7113ce9099222743d9ff02388d3d8a9e987b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-05 | 184 | 54 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 7.30e-05 | 184 | 54 | 4 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.30e-05 | 184 | 54 | 4 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3|lymph-node_spleen / Manually curated celltypes from each tissue | 7.30e-05 | 184 | 54 | 4 | 479e60f76c191253e23699c9dd7ef7efc08c59ad | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-05 | 184 | 54 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-05 | 184 | 54 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 7.45e-05 | 185 | 54 | 4 | f5e14181f45c37d13ee9e017a4c8bc248c353676 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.45e-05 | 185 | 54 | 4 | 241ea1e178fffef9e7df971de739e794332d5173 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.61e-05 | 186 | 54 | 4 | 2cae34336f184f971f7c8684cc27c23a4e7369ed | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.61e-05 | 186 | 54 | 4 | 9579180db2a0bf3f043b4d169f9a08cdc45b459a | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.61e-05 | 186 | 54 | 4 | 90d53c2597a9f3a2b39afba75adfc54f1ca0a4db | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-NP-L5_NP_VISp_Trhr_Cpne7|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.75e-05 | 68 | 54 | 3 | cdb805182f7169fbc3bec31adec3a4e088281757 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.77e-05 | 187 | 54 | 4 | f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1 | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 7.77e-05 | 187 | 54 | 4 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | (6)_ILC|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 7.93e-05 | 188 | 54 | 4 | de7cb273899d0e0748c85f45c6b5e7f0642ab057 | |
| ToppCell | (6)_ILC|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 7.93e-05 | 188 | 54 | 4 | f4734d5b703678670ece204a0519cf015e180a6e | |
| ToppCell | Mesenchymal_cells-Osteoblasts|World / Lineage and Cell class | 7.93e-05 | 188 | 54 | 4 | 89f7f5a51be7e046a63e2413f86c521ae4b6718f | |
| ToppCell | Control-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 8.10e-05 | 189 | 54 | 4 | c76d8af2e0aa4a83ee0c3439c894566fbf117dd3 | |
| ToppCell | (1)_Osterolineage_cells-(10)_OLC-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 8.10e-05 | 189 | 54 | 4 | 46c5b975fb9d33017f2d9b7770d45a8bdf95baa2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.43e-05 | 191 | 54 | 4 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.43e-05 | 191 | 54 | 4 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | COVID-19-kidney-CNT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.60e-05 | 192 | 54 | 4 | 760c6b9628de9693034b00c5025c5c4df94bb2e8 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.60e-05 | 192 | 54 | 4 | 52acaecd3703166f5ce3b328aff7c82bd142fee4 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.60e-05 | 192 | 54 | 4 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.60e-05 | 192 | 54 | 4 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.60e-05 | 192 | 54 | 4 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Vein|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.60e-05 | 192 | 54 | 4 | 81baf1c4063469bb0c03a8602b40e387ba7b0dfb | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.60e-05 | 192 | 54 | 4 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.60e-05 | 192 | 54 | 4 | 20ede290e01ad574afd122d72b59dbc52c595fad | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.78e-05 | 193 | 54 | 4 | 549a0b750c860b615aff767ad04c9a9d20f802f0 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-basal_intermediate_|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 8.78e-05 | 193 | 54 | 4 | 83d2dd823808a2b5ca1a6889eefb541ec042b24c | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.78e-05 | 193 | 54 | 4 | 2f203f6f0c2135acb046c9351a633c3b5b254a46 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.78e-05 | 193 | 54 | 4 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | (1)_Osterolineage_cells|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 8.78e-05 | 193 | 54 | 4 | 035eeea9f77c4bf9cd85f07fa791b6c857be76b5 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.95e-05 | 194 | 54 | 4 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.95e-05 | 194 | 54 | 4 | fb80a0271ccb1cb3f954ebcf2c5945cb6adb6b8c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.95e-05 | 194 | 54 | 4 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.95e-05 | 194 | 54 | 4 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.95e-05 | 194 | 54 | 4 | 292ce9021678534c9eedb367b9772a9d976208a8 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 9.13e-05 | 195 | 54 | 4 | 120296531bbc8080dcabacbd64733cc1dc34603a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.13e-05 | 195 | 54 | 4 | 78cfde21dde4b877fc76c8b0d5ddaabe44b912d7 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.13e-05 | 195 | 54 | 4 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|IPF / Disease state, Lineage and Cell class | 9.13e-05 | 195 | 54 | 4 | 2c3ad3cb79f11119ac69c413a938d21199145040 | |
| ToppCell | IPF-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 9.32e-05 | 196 | 54 | 4 | 7fc9894ceb79dab9f0495acc84e2d6d0d1c69bb7 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.32e-05 | 196 | 54 | 4 | f40d10ea7714067585493fdc89744714aa427de8 | |
| ToppCell | IPF-Stromal-Myofibroblast|IPF / Disease state, Lineage and Cell class | 9.32e-05 | 196 | 54 | 4 | 2d0a48e49b3b37bb66e33e74c52915911e1f8a74 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.32e-05 | 196 | 54 | 4 | f47e551ba484687ba6ce8c29a085106131364042 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.32e-05 | 196 | 54 | 4 | d5ed41fa111750e6b363c04cccc40a47dd774852 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.32e-05 | 196 | 54 | 4 | b8350340d86e4524e9616a427e7f2e116a6fb3be | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.50e-05 | 197 | 54 | 4 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| Drug | AC1LAKND | 1.25e-10 | 62 | 54 | 7 | CID000470146 | |
| Drug | GK-101 | 2.46e-10 | 36 | 54 | 6 | CID000161853 | |
| Drug | BAPN | 3.34e-10 | 71 | 54 | 7 | CID000001647 | |
| Drug | Madecassol | 1.16e-09 | 46 | 54 | 6 | CID000108062 | |
| Drug | halofuginone lactate | 1.21e-09 | 85 | 54 | 7 | CID000062891 | |
| Drug | 4-hydroxyproline | 1.96e-09 | 91 | 54 | 7 | CID000000825 | |
| Drug | d-indobufen | 1.96e-09 | 50 | 54 | 6 | CID000044562 | |
| Drug | ridogrel | 2.50e-09 | 52 | 54 | 6 | CID005362391 | |
| Drug | NSC49633 | 2.82e-09 | 53 | 54 | 6 | CID000023340 | |
| Drug | ticlopidine | 4.69e-09 | 103 | 54 | 7 | CID000005472 | |
| Drug | hydroxylysine | 6.98e-09 | 109 | 54 | 7 | CID000001029 | |
| Drug | Tranilast sodium | 1.02e-08 | 115 | 54 | 7 | CID000005527 | |
| Drug | malotilate | 1.70e-08 | 71 | 54 | 6 | CID000004006 | |
| Drug | AC1NMZ1B | 2.37e-08 | 75 | 54 | 6 | CID005034185 | |
| Drug | strontium ranelate | 2.79e-08 | 77 | 54 | 6 | CID006918182 | |
| Drug | pirfenidone | 3.60e-08 | 138 | 54 | 7 | CID000040632 | |
| Drug | DL-penicillamine | 3.78e-08 | 139 | 54 | 7 | CID000004727 | |
| Drug | PCR 4099 | 3.78e-08 | 139 | 54 | 7 | CID000002806 | |
| Drug | AC1Q6PCP | 6.70e-08 | 230 | 54 | 8 | CID000005267 | |
| Drug | khellin | 1.57e-07 | 171 | 54 | 7 | CID000003828 | |
| Drug | AC1L1DD6 | 2.14e-07 | 179 | 54 | 7 | CID000002299 | |
| Drug | AC1L1C2F | 2.37e-07 | 110 | 54 | 6 | CID000001711 | |
| Drug | PPACK | 2.78e-07 | 113 | 54 | 6 | CID003036757 | |
| Drug | AC1L9732 | 2.93e-07 | 114 | 54 | 6 | CID000439300 | |
| Drug | foscarnet | 3.21e-07 | 190 | 54 | 7 | CID000003414 | |
| Drug | silibinin | 3.45e-07 | 285 | 54 | 8 | CID000005213 | |
| Drug | Selara | 5.05e-07 | 125 | 54 | 6 | CID000150310 | |
| Drug | DMSe | 6.96e-07 | 132 | 54 | 6 | CID000020796 | |
| Drug | AC1L18QD | 9.30e-07 | 325 | 54 | 8 | CID000000213 | |
| Drug | candesartan cilexetil | 1.21e-06 | 145 | 54 | 6 | CID000002540 | |
| Drug | L-lysyl-L-lysyl-L-lysine | 2.30e-06 | 162 | 54 | 6 | CID000072363 | |
| Drug | hyaluronan | 2.82e-06 | 263 | 54 | 7 | CID000024759 | |
| Drug | chondroitin sulfate | 5.49e-06 | 413 | 54 | 8 | CID000024766 | |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | 5.61e-06 | 189 | 54 | 6 | CID000001413 | |
| Drug | Vincamine [1617-90-9]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 7.32e-06 | 198 | 54 | 6 | 3976_UP | |
| Drug | Estrone [53-16-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 7.53e-06 | 199 | 54 | 6 | 6448_DN | |
| Drug | AC1L1KMJ | 1.54e-05 | 476 | 54 | 8 | CID000030956 | |
| Drug | L-3,4-dehydroproline | 2.72e-05 | 73 | 54 | 4 | CID000094284 | |
| Drug | prostacyclin sodium salt | 2.74e-05 | 250 | 54 | 6 | CID000000159 | |
| Drug | losartan | 2.98e-05 | 378 | 54 | 7 | CID000003961 | |
| Drug | colchine | 3.24e-05 | 383 | 54 | 7 | CID000002833 | |
| Drug | Acetylsalicylsalicylic acid [530-75-6]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 9.61e-05 | 194 | 54 | 5 | 2223_UP | |
| Drug | (2s,5s)-5-Carboxymethylproline | 9.71e-05 | 314 | 54 | 6 | CID000447989 | |
| Drug | Deoxycorticosterone [64-85-7]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 9.85e-05 | 195 | 54 | 5 | 5357_DN | |
| Drug | Tocainide hydrochloride; Down 200; 17.4uM; MCF7; HT_HG-U133A | 9.85e-05 | 195 | 54 | 5 | 7351_DN | |
| Drug | Bromperidol [10457-90-6]; Down 200; 9.6uM; HL60; HG-U133A | 9.85e-05 | 195 | 54 | 5 | 1723_DN | |
| Drug | oligomycin; Down 200; 1uM; MCF7; HG-U133A | 1.01e-04 | 196 | 54 | 5 | 442_DN | |
| Drug | THIP Hydrochloride; Up 200; 22.6uM; PC3; HT_HG-U133A | 1.03e-04 | 197 | 54 | 5 | 7266_UP | |
| Drug | Bicuculline (+) [485-49-4]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 1.03e-04 | 197 | 54 | 5 | 2796_DN | |
| Drug | Griseofulvin [126-07-8]; Up 200; 11.2uM; PC3; HT_HG-U133A | 1.03e-04 | 197 | 54 | 5 | 3664_UP | |
| Drug | Carteolol hydrochloride [51781-21-6]; Down 200; 12.2uM; HL60; HT_HG-U133A | 1.06e-04 | 198 | 54 | 5 | 1340_DN | |
| Drug | Amoxicillin [26787-78-0]; Up 200; 11uM; HL60; HT_HG-U133A | 1.06e-04 | 198 | 54 | 5 | 1265_UP | |
| Drug | Buspirone hydrochloride [33386-08-2]; Up 200; 9.4uM; PC3; HT_HG-U133A | 1.06e-04 | 198 | 54 | 5 | 6743_UP | |
| Drug | Flumequine [42835-25-6]; Up 200; 15.4uM; PC3; HT_HG-U133A | 1.06e-04 | 198 | 54 | 5 | 5104_UP | |
| Drug | Hippeastrine hydrobromide [22352-41-6]; Up 200; 10uM; HL60; HT_HG-U133A | 1.08e-04 | 199 | 54 | 5 | 2187_UP | |
| Drug | Moricizine hydrochloride [31883-05-3]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 1.11e-04 | 200 | 54 | 5 | 6000_DN | |
| Disease | serum metabolite measurement | 3.03e-04 | 945 | 54 | 8 | EFO_0005653 | |
| Disease | Burkitt Leukemia | 3.40e-04 | 15 | 54 | 2 | C4721444 | |
| Disease | African Burkitt's lymphoma | 3.40e-04 | 15 | 54 | 2 | C0343640 | |
| Disease | diet measurement, HOMA-B | 5.51e-04 | 19 | 54 | 2 | EFO_0004469, EFO_0008111 | |
| Disease | primary aldosteronism | 1.04e-03 | 26 | 54 | 2 | MONDO_0001422 | |
| Disease | hypertension, COVID-19 | 1.12e-03 | 27 | 54 | 2 | EFO_0000537, MONDO_0100096 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.34e-03 | 447 | 54 | 5 | EFO_0000694, MONDO_0100096 | |
| Disease | Heart Failure, Diastolic | 1.67e-03 | 33 | 54 | 2 | C1135196 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PESHVLVLMKGLPGG | 106 | Q9NPC4 | |
| GHLGLPHGPSGEKMA | 1541 | Q9NYQ6 | |
| LPGPKEGDLAGHDMG | 551 | Q9UI36 | |
| LPGLLGGVGPMHSVV | 1741 | Q2TAZ0 | |
| KNQLPGILGGVGPMH | 1881 | Q96BY7 | |
| LTGLGHMPEPALNPG | 1341 | Q9UKP4 | |
| PDLVHKVIMINGGGP | 266 | Q96I13 | |
| GLPGMKGDPGEILGH | 151 | P02462 | |
| KGDPGEILGHVPGML | 156 | P02462 | |
| EGKLHDPEGMGIIPR | 96 | P33176 | |
| KALMELGGGKPLPHP | 691 | Q5VUB5 | |
| LHEAGMGLEEPGGAP | 396 | O43292 | |
| DPIRGPDGKMHGNLC | 316 | Q9NQ38 | |
| KDGSPLGQDMGPHLR | 3261 | Q8NDA2 | |
| MGLGPGGQPIDANHL | 306 | P52272 | |
| GPMGLQGIQGPKGLD | 421 | Q86Y22 | |
| PGLLVGVPGMVKGLH | 226 | Q9UJ14 | |
| GIVLLLPHGMEGMGP | 761 | Q9ULD0 | |
| LPKMEDGTLQAGPGG | 771 | P54098 | |
| GIPEHLMGKLGPNGE | 836 | Q7LBC6 | |
| MKAFGPPHEGPLQGL | 1 | Q3KR16 | |
| AGPAEPHKGLGMLPV | 161 | O00144 | |
| PGDQEKGEMGLGAVP | 66 | Q5T013 | |
| PGDGIGPELMLHVKS | 61 | P51553 | |
| PGGKVGLLNHRPVAM | 1721 | Q9Y6J0 | |
| LQPLGMGPKNFIHGL | 581 | Q66K79 | |
| MGALKLNLGGAPEGP | 1416 | Q8TD57 | |
| GIMGCHEIPPLKEQG | 276 | Q9P0X4 | |
| IPGPHGTRGLQAMKG | 1396 | A8TX70 | |
| GPMGPSPDLSHIKQG | 286 | Q6UXH8 | |
| GMKGPPGLQGVKGHA | 181 | Q14055 | |
| PDMGLGIDGVKPPHA | 586 | P27658 | |
| QKGDQGHPGVPGFMG | 1181 | Q8NFW1 | |
| MGLPGQEGLPGKDGD | 1296 | Q8NFW1 | |
| PGIPGHKGHTGLMGP | 1416 | Q8NFW1 | |
| HKGHTGLMGPQGLPG | 1421 | Q8NFW1 | |
| PEGIPGSGHKPNSML | 226 | Q9NS73 | |
| GGGHVPERPKQEMLL | 51 | P33241 | |
| GHKGEMGEPGVPGQS | 2656 | Q02388 | |
| NGHGKAMALGEGPPL | 1066 | Q9BXA9 | |
| HGGVIPMHGNGLELP | 251 | Q9UKN5 | |
| SPGNIGKLLGPLPMH | 286 | Q99567 | |
| VGGALLGPMVLSKHP | 91 | Q9NUT2 | |
| GMPKGLAHQLASPGL | 556 | P42345 | |
| HGSMPGKTAIELGPL | 516 | Q7Z2T5 | |
| LGSGMPLGKEGPFVH | 196 | P51788 | |
| EVHLPNIKPGEGLGM | 211 | G9CGD6 | |
| APDHGGLISKMLPGQ | 286 | Q15846 | |
| EVHLPNIKPGEGLGM | 211 | Q6P9H4 | |
| PVPGEKGDQGLSGLM | 546 | Q17RW2 | |
| HLGLMGPDGEPGIPG | 1156 | Q17RW2 | |
| GPHIPGMEGEVLPKN | 321 | Q6GYQ0 | |
| ELERMNPGPGGKLGH | 226 | P41440 | |
| VMPPALGEVGGHLGG | 506 | A1YPR0 | |
| MLGDLEEEGPGGAHP | 196 | Q9UDV6 | |
| LPGMAALQPHGVPGD | 511 | Q9ULE0 | |
| ALGHKNGPVHGMGPA | 396 | Q9Y493 | |
| GGHPHPLNGQMRLGL | 271 | Q96T25 | |
| PHGEPIKMRIGLHSG | 566 | Q02108 | |
| PGMDFPGPHEKGLVL | 131 | Q9NR64 |